NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) (PAR-24-120)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) (RFA-MH-25-170)

Sponsor: National Institutes of Health

Award: NIH BRAIN and partner components intend to commit an estimated total of $3M in fiscal years 2025, 2026, 2027 to fund up to 8 new awards, each year, contingent upon annual appropriations. Application budgets are limited to $300,000 in direct costs in any project year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) (RFA-MH-25-171)

Sponsor: National Institutes of Health

Award: NIH BRAIN and partner components intend to commit an estimated total of $2M in fiscal years 2025, 2026, 2027 to fund up to 8 new awards each year for this RFA, contingent upon annual appropriations. The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: Multiple due dates; see announcement.

NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) (RFA-NS-24-030)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) (PAR-24-095)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (PAR-24-096)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Budgets up to $700,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested.

Due Date: Multiple due dates; see announcement.

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) (PAR-24-097)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (PAR-24-098)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Budgets up to $700,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested. The maximum project period is 4 years.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Use of Digital Technology and mHealth `to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome (R21) (NOT-OD-24-044)

Sponsor: National Institutes of Health

Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research

Sponsor: Glenn Foundation for Medical Research(“GFMR”), in partnership with the American Federation for Aging Research (AFAR)

Award: Ten awards of $75,000

Due Date: Deadline for Letters of Intent: January 25, 2024

Hevolution Foundation Scientific Conferences Fund

Sponsor: The Hevolution Foundation

Award: Up to $10,000 per meeting

Due Date: January 31, 2024

Glenn Foundation Discovery Award

Sponsor: Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research

Award: Two awards of $525,000

Due Date: Deadline for Letters of Intent: February 15, 2024

Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)

Sponsor: National Institutes of Health (NIH)

Due Date: Earliest submission date: May 10, 2024

Notice of Intent to Publish an FOA for Open Measurement Coordinating Network for Non-Pharmacological AD and ADRD Primary Prevention Trials (U24 Clinical Trial Not Allowed) (NOT-AG-23-061)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: February 01, 2024. First Estimated Application Due Date: June 07, 2024.

NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) (PAR-23-311)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.